Federated Hermes’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Federated Hermes’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-63	Closed	-$2K	–	2372
2021 Q4	$2K	Hold	63	–	–	﹤0.01%	2075
2021 Q3	$2K	Buy	+63	New	+$1.13K	﹤0.01%	2115
2021 Q1	–	Sell	-304	Closed	-$2K	–	2396
2020 Q4	$2K	Buy	304 +56	+23%	+$441	﹤0.01%	2144
2020 Q3	$2K	Hold	248	–	–	﹤0.01%	2117
2020 Q2	$2K	Buy	+248	New	+$2.57K	﹤0.01%	2111

Other funds holding OPNT

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OCM

Ovata Capital Management Hong Kong $715M AUM 19.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Federated Hermes's OPNT Position: Q1 2022 in Review

Federated Hermes sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2022, closing a stake of 63 shares — an estimated $2K sold.

Federated Hermes first reported a position in OPNT in Q2 2020 and held it in 5 quarters. The position peaked at $2K in Q4 2021. 41 funds tracked by Wall St. Rank hold OPNT as of Q1 2022.

Federated Hermes reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Federated Hermes sold 63 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $2K.
Federated Hermes first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
Federated Hermes's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q4 2021.
41 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.